Novartis | NOVN - Stock

Stock Price
130.36
Daily Change
2.26 1.76%
Monthly
14.15%
Yearly
33.48%
Q1 Forecast
123.39

Novartis reported $6.42B in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Alcon AG USD 2.39B 51M Jun/2025
Amgen USD 6.22B 121M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
Autolus Therapeutics Ltd USD 27.72M 3.78M Sep/2025
Bayer EUR 12.33B 221M Sep/2025
Biogen USD 2.17B 41.3M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Fresenius EUR 2.59B 44M Jun/2025
Fresenius Medical Care EUR 2.09B 90.5M Sep/2025
Galapagos EUR 22.95M 15.57M Sep/2025
Genmab DKK 13M 1000K Jun/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
GRIFOLS EUR 3.35B 213.23M Jun/2025
Hikma Pharmaceutical USD 1.08B 96M Jun/2025
J&J USD 14.19B 45M Dec/2025
Lonza CHF 1.68B 163M Dec/2025
Merck EUR 4.47B 45M Jun/2025
Merck USD 6.44B 157M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Orion EUR 456.3M 12.6M Dec/2025
Pfizer USD 11.47B 201M Sep/2025
Philips EUR 3.26B 28M Sep/2025
Recordati EUR 505.2M 11.57M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025
UCB EUR 1.31B 173M Dec/2024